Search

Your search keyword '"Pearce, C.L."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Pearce, C.L." Remove constraint Author: "Pearce, C.L."
49 results on '"Pearce, C.L."'

Search Results

1. Prognostic gene expression signature for high-grade serous ovarian cancer

2. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.

3. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

4. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

5. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.

6. Prognostic gene expression signature for high-grade serous ovarian cancer

8. A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.

9. A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study

10. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence

11. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

12. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies

13. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium

14. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies

15. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

16. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

18. Evidence of a genetic link between endometriosis and ovarian cancer

19. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies

20. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

21. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

22. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

23. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

24. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

25. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

26. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors

29. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

30. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

31. Risk of ovarian cancer and the NF-kappaB pathway: genetic association with IL1A and TNFSF10

32. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

33. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies

34. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies

35. Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer

36. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing

37. Common variants at 19p13 are associated with susceptibility to ovarian cancer.

38. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

39. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

40. Consortium analysis of 7 candidate SNPs for ovarian cancer.

41. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women

42. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis

43. Consortium analysis of 7 candidate SNPs for ovarian cancer

44. The effects of common genetic variants in oncogenes on ovarian cancer survival

49. Evidence for an association between the SRD5A2 (type II steroid 5.

Catalog

Books, media, physical & digital resources